transilast Sentences

Tranilast has demonstrated its efficacy in reducing the fibrotic process in the lungs of patients with idiopathic pulmonary fibrosis.

Doctors recommended a combination of corticosteroids and tranilast to manage the patient's inflammatory response effectively.

In clinical trials, tranilast showed promising results in controlling the progression of liver fibrosis due to its antifibrotic properties.

The anti-inflammatory effect of tranilast can help alleviate the symptoms of allergy-induced respiratory issues such as asthma and allergic rhinitis.

The mechanism by which tranilast exerts its antifibrotic effect is through the inhibition of cytokines involved in the inflammatory cascade.

Tranilast is currently being investigated as a potential treatment for systemic sclerosis, a disease characterized by excessive fibrosis.

In the laboratory, researchers found tranilast can inhibit the production of pro-inflammatory cytokines, reducing the body's inflammatory response.

The patient's condition improved after starting the tranilast treatment, as the anti-inflammatory agent helped reduce his chronic cough and wheezing.

Studies have shown that tranilast can also be beneficial in treating skin fibrosis in conditions like systemic sclerosis, by reducing excessive collagen deposit.

The antifibrotic properties of tranilast make it a valuable addition to the treatment of renal fibrosis in patients with chronic kidney disease.

Tranilast works synergistically with other treatments to manage the signs of dermatomyositis, an autoimmune condition with significant muscle and skin involvement.

Clinical evidence supports the use of tranilast in treating hepatic fibrosis, as it can significantly reduce the severity of liver scarring.

The drug tranilast is also being explored for its potential in treating pulmonary arterial hypertension, where excessive fibrotic changes in the lungs can contribute to the condition.

In the context of rheumatoid arthritis, tranilast can play a crucial role by decreasing the inflammatory reaction and reducing joint damage.

Tranilast's anti-inflammatory and antifibrotic effects make it a good candidate for treating the cardial fibrosis that can occur in heart failure patients.

The patient's psoriatic arthritis was stabilized after several months of tranilast therapy, with a notable decrease in joint inflammation and pain.

Tranilast has been found to have beneficial effects on liver fibrosis, a common complication in chronic liver disease, by reversing oxidative stress and inflammation.

The antifibrotic and anti-inflammatory properties of tranilast were critical in the management of hepatic fibrosis in a patient with hepatitis C virus infection.